ABSTRACT
The COVID-19 pandemic is an additional burden on Lebanon’s stressed population, fragmented healthcare system, and political, economic, and refugee crises. Understanding the population’s intentions to vaccinate, and perceptions of and obstacles to SARS-CoV-2 vaccination, can inform Lebanon’s vaccination efforts. We performed a cross-sectional study from 29 Jan 2021 to 11 Mar 2021 using an online questionnaire in Arabic via convenience “snowball” sampling to assess the perceptions of adults residing in Lebanon. 1,185 adults participated in the survey. % [95% CI: 43.2%-49.0%] of survey participants intended to take the SARS-CoV-2 vaccine when available to them, 19.0% [16.8%-21.4%] indicated that they would not, and 34.0% [31.3%-36.8%] were unsure. The most common reasons for hesitancy were concerns about safety, limited testing, side effects, and efficacy. Vaccine hesitancy appears to be high in Lebanon. Disseminating clear, consistent, evidence-based safety and efficacy information on vaccines may help reduce vaccine hesitancy, especially among the large proportion of adults who appear to be unsure about (rather than opposed to) vaccination.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by a Capacity Building and Policy Engagement Grant from the Stanford King Center on Global Development.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Institutional Review Boards of the University of California, Berkeley; the Modern University for Business and Science, Lebanon; and Stanford University (by reliance agreement with the University of California, Berkeley). Informed consent was obtained from all participants prior to the survey; a waiver of written informed consent was granted.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Data Availability
Deidentified data from this study is available upon request from narraj@berkeley.edu and will be stored in the appendix of the corresponding scientific journal in which it is eventually published.
